Search

everythinglearnresearchcommunity

for

Search:↓

Fractional laser therapy may help regrow hair in alopecia areata.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

JAK inhibitors show promise as a future treatment for hair loss.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Both treatments for localized alopecia areata are equally effective.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.